Abstract
We carried out clinical studies on cefozopran (CZOP, SCE-2787). The results are summarized as follows.
Treatment with CZOP was made in 17 cases of pediatric bacterial infections including 2 cases of purulent tonsillitis, 11 cases of acute pneumonia and 2 cases each of urinary tract infections and enteritis. Results obtained were excellent in 12 cases, good in 2 cases, fair in 2 cases and poor in 1 case.
All of 9 isolated bacteria were eradicated by the treatment.
As side effects and laboratory test results, rash was observed in one case and transient increase of platelets in one case, slight increase of eosinophil in 2 cases and transient elevation of GPT and GOT·GPT in one case.
